Foundayo Tab 17.2mg x 30

Foundayo 17.2mg film-coated tablets contain orforglipron, an oral glucagon-like peptide-1 (GLP-1) receptor agonist. It is a prescription-only medicine authorised in the UK for weight management in eligible adults and to improve glycaemic control in adults with insufficiently controlled type 2 diabetes.

Foundayo works by activating GLP-1 receptors involved in appetite regulation and glucose metabolism. For weight management, it is used alongside a reduced-calorie diet and increased physical activity. The 17.2mg strength is the highest authorised tablet strength of Foundayo and is intended for patients who have progressed through the prescribed dose-escalation schedule, where clinically appropriate.

Delivery and Returns

SKU: SK-01068 Category: Tags: , Brands:

Benefits

  • Oral GLP-1 treatment: Contains orforglipron in tablet form.
  • Weight management: Used alongside dietary and physical activity changes in eligible adults.
  • Blood glucose control: Also authorised for adults with insufficiently controlled type 2 diabetes.
  • Once-daily formulation: Taken according to the prescribing clinician’s instructions.
  • Highest tablet strength: The 17.2mg strength is the highest available Foundayo tablet dose.

Features

  • Active ingredient: Orforglipron
  • Strength: 17.2mg per tablet
  • Pack size: 30 film-coated tablets
  • Administration: Oral
  • Dosing frequency: Once daily, as prescribed
  • Food restrictions: May be taken with or without food, at any time of day.
  • Treatment approach: Used alongside appropriate lifestyle measures.
  • Prescription status: Prescription-only medicine.

Why Choose

Foundayo provides an oral treatment option for eligible adults requiring medical management of weight or type 2 diabetes. Its active ingredient, orforglipron, acts on GLP-1 receptors involved in appetite regulation and glucose metabolism.

The 17.2mg strength is intended for use within an individually prescribed treatment plan after gradual dose escalation. The appropriate dose depends on treatment response, tolerability, other medicines and clinical considerations.

Common Uses

Weight management: Used alongside a reduced-calorie diet and increased physical activity in adults with a BMI of 30kg/m² or above, or a BMI of 27–29.9kg/m² with at least one weight-related health condition.

Type 2 diabetes: Used alongside diet and exercise to improve blood glucose control in adults whose type 2 diabetes is insufficiently controlled. It may be prescribed alone when metformin is inappropriate or alongside other diabetes medicines, as clinically appropriate.

How It Works

Foundayo contains orforglipron, a non-peptide GLP-1 receptor agonist. It activates GLP-1 receptors involved in appetite regulation and glucose metabolism.

Its effects include reducing food intake, supporting weight reduction and improving blood glucose control. It also delays gastric emptying, particularly after the initial dose, with this effect diminishing over time.

Foundayo should be used only as prescribed and alongside the lifestyle measures recommended by the treating healthcare professional.

What is Foundayo 17.2mg used for?
Foundayo is authorised for weight management in eligible adults and for improving glycaemic control in adults with insufficiently controlled type 2 diabetes. It is used alongside appropriate diet and physical activity measures.
What is the active ingredient in Foundayo?
The active ingredient is orforglipron, an oral GLP-1 receptor agonist.
How is Foundayo 17.2mg taken?
Foundayo is taken orally once daily, at any time of day, with or without food. Tablets should be swallowed whole. Patients must follow their prescribed dose and should not change it without advice from their prescriber.
Is 17.2mg the starting dose?
No. Treatment starts at a lower strength and is increased gradually, with at least 30 days on each dose before a potential increase. The 17.2mg strength is the highest tablet dose and should only be used when prescribed following appropriate dose escalation and clinical assessment.

Related products